HMPL004-6599 Phase I Dose-escalating Study

NCT03597971 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Ulcerative Colitis
Crohn Disease

Interventions

DRUG: HMPL004-6599
DRUG: Placebo

Sponsor

Nutrition Science Partners Limited

Collaborators

[object Object]
[object Object]